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Abstract
Resveratrol, a polyphenol presents in grapes and wine, displays antioxidant and anti-inflammatory properties and
cytoprotective effect in brain pathologies associated to oxidative stress and neurodegeneration. In previous work, we
demonstrated that resveratrol exerts neuroglial modulation, improving glial functions, mainly related to glutamate
metabolism. Astrocytes are a major class of glial cells and regulate neurotransmitter systems, synaptic processing, energy
metabolism and defense against oxidative stress. This study sought to determine the protective effect of resveratrol against
hydrogen peroxide (H2O2)-induced cytotoxicity in C6 astrocyte cell line, an astrocytic lineage, on neurochemical parameters
and their cellular and biochemical mechanisms. H2O2 exposure increased oxidative-nitrosative stress, iNOS expression,
cytokine proinflammatory release (TNFa levels) and mitochondrial membrane potential dysfunction and decreased
antioxidant defenses, such as SOD, CAT and creatine kinase activity. Resveratrol strongly prevented C6 cells from H2O2-
induced toxicity by modulating glial, oxidative and inflammatory responses. Resveratrol per se increased heme oxygenase 1
(HO1) expression and extracellular GSH content. In addition, HO1 signaling pathway is involved in the protective effect of
resveratrol against H2O2-induced oxidative damage in astroglial cells. Taken together, these results show that resveratrol
represents an important mechanism for protection of glial cells against oxidative stress.
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Introduction
The polyphenol resveratrol (3,5,49-trihydroxy-trans-stilbene), a
redox active compound, is a phytoalexin found in a wide variety of
dietary sources including grapes, peanuts and wines, especially red
wines [1,2,3,4,5]. Resveratrol presents important antioxidant
properties, possibly by its direct scavenging effect and/or
activation of pathways those upregulate natural antioxidant
defenses [6,7]. Many studies have shown that resveratrol can
prevent or slow the progression of a wide variety of illnesses,
including cancer [8] and cardiovascular diseases [9,10] and
improves health and survival of mice on a high-calorie diet [11].
Moreover, it has been demonstrated that resveratrol has beneficial
effects in neurological diseases [6,12,13,14] and is able to inhibit b-
amyloid peptide neurotoxicity [15,16]. Whilst direct protective
effects of resveratrol against oxidative stress have been demon-
strated in neuroglial cells [14,17,18,19,20,21,22], the mechanisms
of these effects are not fully understood.
Reactive oxygen species (ROS), such as hydrogen peroxide
(H2O2), are generated during normal cellular metabolism, playing
important roles in signaling pathways [23,24]. However, H2O2
also presents toxicological effects, because it can produce new
radicals and induces damage to major cellular constituents
[25,26,27]. Moreover, it has been demonstrated that exogenous
H2O2 promotes an imbalance between production and removal of
ROS towards the pro-oxidative state, often referred to as oxidative
stress.
Heme oxygenase (HO) is the rate-limiting enzyme in the
degradation pathway of pro-oxidant heme into biliverdin/
bilirubin (both known antioxidants) and has two isoforms: the
inducible HO1 and the constitutive HO2 [28]. In the central
nervous system (CNS), HO pathway has been reported to be
active and to operate as a fundamental defensive mechanism for
cells exposed to an oxidant challenge [29]. Increases in HO1
protein levels are associated to protection against stress conditions,
such as oxidative stress and hypoxia [30]. HO1 is able to inhibit
inducible nitric oxide synthase (iNOS) activity [31], an isoform of
nitric oxide synthase that catalyze the synthesis of nitric oxide
(NO) from L-arginine. NO plays a physiological role in neuronal
cell signaling, but, when in elevated levels, NO becomes noxious,
can interact with superoxide anion (generated by mitochondria or
by other mechanisms) leading to the overproduction of powerful
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oxidant species peroxynitrite [32]. This toxic compound belongs to
a family known as reactive nitrogen species or RNS, which cause
cellular damage [33,34]. It has been frequently suggested that
polyphenols help to regulate the ROS/RNS imbalance [29,35,36]
with potential effect on neuroglial plasticity modulation, including
astrocytes activity regulation [14].
Astrocytes have been shown to be involved in the regulation of
the brain microenvironment, in particular regarding neurotrans-
mitter systems and ionic homeostasis, synaptic transmission,
metabolic support, free-radical scavenging, maintenance of the
blood-brain barrier and immune function [37,38,39]. Astrocytes
express numerous receptors that enable them to respond to various
neuroactive compounds, including neurotransmitters, neuropep-
tides, growth factors, cytokines, small molecules and toxins [40].
The C6 astrocyte cell line [98% GFAP (glial fibrillary acidic
protein) positive after 100 passages] are widely used as an
astrocyte-like cell line to study astrocytic function, e.g. glutamate
uptake, glutamine synthetase activity, S100B secretion and
parameters of oxidative stress. Moreover, this cell line responds
quickly to external stimuli, such as H2O2, which can generate
oxidative-nitrosative stress [17,41].
Recently, our group has reported that resveratrol was able to
modulate important glial parameters involved in brain plasticity
and prevents lipid peroxidation, DNA damage and genotoxicity
induced by H2O2 exposure in astroglial cells [14,17,41]. Thus, in
the present study, we investigated the effect of resveratrol against
H2O2-induced toxicity in C6 astrocyte cell line on neurochemical
parameters and their cellular and biochemical mechanisms. Nitrite
production; the expression of iNOS and HO1 proteins; intracel-
lular ROS production; total antioxidant reactivity (TAR) levels;
mitochondrial membrane potential and creatine kinase (CK)
activity were assessed. The activity of the main antioxidant
enzymes: superoxide dismutase (SOD – EC 1.15.1.1), catalase
(CAT – EC 1.11.1.6) and glutathione peroxidase (GPx – EC
1.11.1.9); the extracellular glutathione (GSH) levels and tumor
necrosis factor a (TNFa) levels were also evaluated. Additionally,
the mechanism of the protective effect of resveratrol against H2O2-
oxidative insult was also explored.
Materials and Methods
Materials
Resveratrol, chemical reagents, anti-iNOS and cell culture
materials were purchased from Sigma (St. Louis, MO, USA),
except for Dulbecco’s Eagle’s medium (DMEM), fetal bovine
serum (FBS) and JC-1, which were purchased from Gibco/
Invitrogen (Carlsbad, CA, USA). Anti-HO1 was obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). RANSOD was
purchased from Randox (Crumlin, CA, UK). All other chemicals
were purchased from local commercial suppliers.
Maintenance of Cell Culture
The C6 astrocyte cell line were obtained from the American
Type Culture Collection (Rockville, MD, USA) and were
maintained essentially according to previously described [42].
The cells were seeded in flasks and cultured in DMEM (pH 7.4)
containing 5% FBS, 2.5 mg/mL FungizoneH and 100 U/l
gentamicin. Cells were kept at a temperature of 37uC in an
atmosphere of 5% CO2/95% air. Exponentially growing cells
were detached from the culture flasks using 0.05% trypsin/
ethylene-diaminetetracetic acid (EDTA) and seeded 106103 cells/
cm2 in 96-, 24- or 6-well plates.
Resveratrol and Hydrogen Peroxide Treatment
After cells reached confluence, the culture medium was
removed from well plates and cells were pre-incubated in the
absence or presence of 100 mM of resveratrol for 1 h, in serum-
free DMEM (pH 7.4). After pre-incubation, resveratrol was
maintained and 1 mM H2O2 was added for 0.5 h. During all
procedure, cells were maintained at 37uC in an atmosphere of 5%
CO2/95% air. Control cells were exposed to 0.25% ethanol
vehicle. For all parameters analyzed, the results obtained with
vehicle were not different from those obtained under basal
conditions without ethanol.
Nitric Oxide Production
Nitric oxide was determined by measurement of nitrite (a stable
oxidation product of NO), based on the Griess reaction. The
Griess reagent was prepared by mixing equal volumes of 1%
sulfanilamide in 0.5 M HCl and 0.1% N-(1-naphthyl) ethylenedi-
amine in deionized water. The assay was performed as described
[43], with modifications. Briefly, cells were cultured on 96-well
plate and after treatment, the Griess reagent was added directly to
the cell culture and the incubation was maintained under reduced
light at room temperature during 15 min. Samples were analyzed
at 550 nm on a microplate spectrophotometer. Controls and
blanks were run simultaneously. Nitrite concentrations were
calculated using a standard curve prepared with sodium nitrite
(0–50 mM).
Western Blot Analysis
Cells were removed from plates after treatments using lysis
solution with 4% SDS, 2 mM EDTA, 50 mM Tris-HCl, pH 6.8.
Equal amounts of proteins from each sample were boiled in
sample buffer [62.5 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 5% b-
mercaptoethanol, 10% (v/v) glycerol, 0.002% (w/v) bromophenol
blue] and submitted to electrophoresis in 10% (w/v) SDS-
polyacrylamide gel. The separated proteins were blotted onto a
nitrocellulose membrane. Equal loading of each sample was
confirmed with Ponceau S staining (Sigma). The following
polyclonal antibodies were used: anti-iNOS (1:10000; Sigma)
and anti-HO1 (1:3000; Santa Cruz). b-actin was used as a loading
control. After incubating overnight with the primary antibody at
room temperature, membranes were washed and incubated with
peroxidase-conjugated anti-rabbit immunoglobulin (IgG) at a
dilution of 1:1000 for 1 h. The chemiluminescence signal was
detected using an ECL (Amersham), after the films were scanned
and bands were quantified using the Scion Image software.
Intracellular ROS Production
DCFH oxidation was used to measure intracellular ROS
production. DCFH-DA (29-79-dichlorofluorescein diacetate) is
hydrolyzed by intracellular esterases to dichlorofluorescin
(DCFH), which is trapped within the cell. This non-fluorescent
molecule is then oxidized to fluorescent dichlorofluorescin (DCF)
by action of cellular oxidants. To test whether HO1 was involved
in the effect of resveratrol against H2O2-induced increase ROS
production, we used its specific inhibitor, Zinc Protoporphyrin IX
(ZnPP IX) 10 mM, for 0.5 h before the treatment described for
resveratrol and H2O2. After, cells were treated with DCFH-DA
(10 mM) for 0.5 h at 37uC. Following DCFH-DA exposure, the
cells were scraped into PBS with 0.2% Triton X-100. The
fluorescence was measured in a plate reader (Spectra Max
GEMINI XPS, Molecular Devices, USA) with excitation at
485 nm and emission at 520 nm [17]. The ROS production was
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calculated as Unit of Fluorescence – UF/mg protein and was
expressed as percentage of control.
Total Antioxidant Reactivity (TAR)
TAR, which represents the reactivity of the tissue antioxidants,
was determined by measuring the luminol chemiluminescence
intensity induced by 2,29-azo-bis-(2-amidinopropane) (ABAP) [44].
The background chemiluminescence was measured by addicting
2 mM ABAP (in 0.1 M glycine buffer, pH 8.6) into a glass
scintillation vial. After, luminol (4 mM) were added to each vial
and the chemiluminescence was determined. This was considered
to be the basal value. Cell homogenates were then added and the
chemiluminescence was measured during 60 s. The addition of
trolox (calibration curve) or cells supernatants reduce the
chemiluminescence and this rapid reduction in luminol intensity
is considered measure of TAR capacity. The ratio between the
initial and the final chemiluminescente values was used to
calculate TAR. TAR values were calculated as nmol trolox/mg
protein and are presented as percentage of control.
Mitochondrial Membrane Potencial (JC-1 assay)
For determination of the mitochondrial membrane potential,
after resveratrol and H2O2 treatments, cells were incubated for
0.5 h with JC-1 (5,59,6,69-tetrachloro-1,19,3,39-tetraethylbenzimi-
dazolylcarbocyanine iodide, 2 mg/ml). After, cells were centri-
fuged, washed once with HBSS and transferred to a 96-well plate
and fluorescence was measured using excitation and emission
wavelengths of 485 and 540/590 nm, respectively. The mito-
chondrial membrane potential was calculated using the ratio of
590 nm (red fluorescent J-aggregates)/540 nm (green monomeric)
[45,46].
Creatine Kinase (CK) Activity
Cells were homogenized with a 0.9% saline solution and pre-
incubated for 15 min at 37uC in a mixture containing: 7 mM
phosphocreatine, 9 mM MgSO4, 60 mM Tris–HCl buffer
(pH 7.5). Incubation was started by the addition of 3.2 mM
ADP plus 0.8 mM reduced glutathione. The reaction was stopped
after 10 min by the addition of 10 mmol p-hydroxymercuribenzoic
acid. The reagent concentrations and the incubation time were
chosen to assure linearity of the enzymatic reaction. Appropriate
controls were carried out to measure chemical hydrolysis of
phosphocreatine. The creatine formed was estimated according to
the colorimetric method [47]. The color was developed by the
addition of 20% a-naphthol and 20% diacetyl and read after
20 min at 540 nm. Results were obtained as mmol of creatine
formed/min/mg protein.
Superoxide Dismutase (SOD) Activity
SOD activity was determined using the RANSOD kit from
Randox (Autrim, UK). The method is based on the formation of
red formazan from the reaction of 2-(4-iodophenyl)-3-(4-nitrophe-
nol)-5-phenyltetrazolium chloride and superoxide radical pro-
duced in the incubation medium from the xanthine and xanthine
oxidase reaction system, which is assayed spectrophotometrically
at 505 nm. The inhibition of the produced chromogen is
proportional to the activity of the SOD present in the sample. A
50% inhibition is defined as one unit of SOD and the specific
activity is represented as U/mg protein.
Catalase (CAT) Activity
CAT activity was assayed by the method of Aebi [48], by
measuring the absorbance decrease at 240 nm in a reaction
medium containing 20 mM H2O2, 0.1% Triton X-100, 10 mM
potassium phosphate buffer, pH 7.0 and 50 mg protein. One unit
(U) of the enzyme is defined as 1 mmol of H2O2 consumed per
minute and the specific activity is reported as U/mg protein.
Glutathione Peroxidase (GPx) Activity
GPx activity was measured by the method of Wendel [49], using
tert-butyl-hidroperoxide as substrate. GPx activity was determined
by monitoring NADPH (0.1 mM) disappearance at 340 nm in a
medium containing 2 mM GSH, 0.15 U/ml glutathione reduc-
tase, 0.4 mM azide and 0.5 mM tert-butyl-hidroperoxide. One
GPx unit is defined as 1 mmol of NADPH consumed per minute
and the specific activity is represented as U/mg protein.
Extracellular Glutathione (GSH)
Extracellular GSH levels were measured according to Browne
and Armstrong with modifications [17,50]. We also examined the
effect of HO1 inhibitor on extracellular GSH levels, incubating
Zinc Protoporphyrin IX (ZnPP IX) 10 mM, for 0.5 h before the
treatment described for resveratrol and H2O2. Extracellular
medium were diluted in 100 mM sodium phosphate buffer,
pH 8.0, containing 5 mM EDTA, and protein was precipitated
with 1.7% meta-phosphoric acid. After centrifugation, supernatant
was assayed with o-phthaldialdeyde (1 mg/mL methanol) at room
temperature for 15 min. Fluorescence was measured using
excitation and emission wavelengths of 350 and 420 nm,
respectively. A calibration curve was performed with standard
GSH (0–500 mM) and the concentrations were calculated as
nmol/mg of protein. The results were expressed as percentage of
control.
Tumor Necrosis Factor a (TNFa) Levels
This assay was carried out in extracellular medium, using a rat
TNFa ELISA from PeproTech (USA). To test whether the effect
of resveratrol against H2O2-induced TNFa levels was through
HO1, we used a specific inhibitor, Zinc Protoporphyrin IX (ZnPP
IX) 10 mM, for 0.5 h before the treatment described for
resveratrol and H2O2.
Protein Determination
Protein content was measured by Lowry’s method using bovine
serum albumin as standard [51].
Statistical Analysis
All quantitative data and experiments described in this study
were repeated at least three times. Results are expressed as mean
6 S.E.M. Differences between groups were analyzed statistically
by two way analysis of variance (ANOVA) followed by the Tukeys
test using SPSS (Statistical Package for the Social Sciences
software, version 16.0 for Windows). Values of P,0.05 were
considered statistically significant.
Results
Resveratrol Decreased Nitrite Levels
The production of NO was indirectly measured by the
formation of nitrite, expressed in mM. Resveratrol per se decreased
nitrite production, from 1360.9 to 1160.7 mM, compared to the
control conditions (Fig. 1). H2O2 increased nitrite formation up to
16% (from 1360.9 to 15.160.7 mM). This effect was completely
prevented by resveratrol. To test whether decreased in nitrite
accumulation induced by resveratrol was dependent on NOS
activity, we examined the effect of resveratrol in the presence of
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the L-NAME (Nv-nitro-L-arginine methyl ester), a NOS inhibitor.
The co-incubation of resveratrol with L-NAME decreased the
nitrite levels up to 22% compared to the basal value (Fig. 1).
Resveratrol Prevented H2O2-induced iNOS Expression
Considering that the excess production of NO, generated
primarily by iNOS, has been implicated as a mediator of cellular
injury, we aimed to determine the effect of resveratrol on iNOS
expression in the presence of H2O2. As expected, H2O2 increased
iNOS immunocontent (about 50%) compared with the control
conditions (Fig. 2). This effect was inhibited by resveratrol to
values near to basal levels, indicating that resveratrol could
effectively suppress iNOS expression, which was stimulated by
H2O2.
Resveratrol Enhanced HO1 Expression
Increases in HO1 protein levels are associated to protection
against stress conditions, such as oxidative stress, hypoxia and
neurodegenerative disorders [7]. Then we evaluated the immu-
nocontent of this enzyme. Fig. 3 shows that resveratrol per se and
under oxidative insult was able to increase the expression of HO1
(by about 40% and 30%, respectively) in C6 astrocyte cell line.
H2O2 did not affect the HO1 expression.
Resveratrol Reduced Intracellular ROS Production
through HO1
As an imbalance between production and removal of ROS
toward the pro-oxidative state can be promoted by the cellular
exposure to H2O2, we investigated the effect of resveratrol and
resveratrol combined with HO1 inhibitor on intracellular ROS
production by DCFH oxidation method (Fig. 4). Resveratrol per se
decreased by about 16% the DCFH oxidation compared to
control conditions. In addition, resveratrol was able to prevent the
increase of ROS production induced by H2O2. When cells were
pre-incubated with ZnPP IX (10 mM) resveratrol partially
decreased DCFH oxidation and did not prevent the effect of
H2O2 exposure, indicating that antioxidant effect of resveratrol
probably was through HO1. Interestingly, under HO1 inhibitor,
H2O2 potentiated the increase in ROS levels.
Resveratrol Increased Total Antioxidant Reactivity (TAR)
Resveratrol increased (50%) TAR levels compared to control
conditions (Fig. 5). Under oxidative insult the TAR levels were
reduced by about 15% compared to basal value. This effect was
completely prevented by resveratrol, which increased TAR levels
up to 55%, compared to H2O2-oxidative insult.
Resveratrol Prevented Mitochondrial Dysfunction
The mitochondria have emerged as key regulators of oxidative
stress and cytotoxicity [32,52]. As expected H2O2 reduced the
mitochondrial membrane potential by about 25%, inducing
mitochondrial dysfunction and resveratrol completely prevented
this effect (Fig. 6). Resveratrol per se did not affect the
mitochondrial membrane potential.
Resveratrol Prevented the Impairment in CK Activity
Induced by H2O2
The enzyme CK is a target of ROS/RNS and we evaluated the
effect of resveratrol on the CK activity in the presence or absence
of H2O2 (Fig. 7). As expected, oxidative insult decreased CK
activity by 15% (from 1.560.1 to 1.360.1) and resveratrol was
able to completely prevent this effect. Resveratrol per se did not
affect CK activity.
Figure 1. Resveratrol decreased nitrite production. Cells were
pre-treated for 1 h with 100 mM resveratrol (RSV) followed by the
addition of 1 mM H2O2 for 0.5 h. Nitrite production was measured as
described in the Experimental procedures section. Data represent mean
6 S.E.M of three independent experimental determinations performed
in triplicate, analyzed statistically by two-way ANOVA followed by the
Tukey’s test. (a) indicates significant differences from control (P,0.05).
(b) indicates significant differences from H2O2 (P,0.05). (c) indicates
significant differences from L-NAME (P,0.05).
doi:10.1371/journal.pone.0064372.g001
Figure 2. Effects of resveratrol on iNOS expression. Cells were
pre-treated for 1 h with 100 mM resveratrol (RSV) followed by the
addition of 1 mM H2O2 for 0.5 h. Western blot for iNOS was performed
as described in the Experimental procedures section. Data are
expressed as percentage of control value (assumed to be 100%) and
represent the optical density (OD) of mean 6 S.E.M of three
independent experimental determinations performed in triplicate,
analyzed statistically by two-way ANOVA followed by the Tukey’s test.
(a) indicates significant differences from control (P,0.01). (b) indicates
significant differences from H2O2 (P,0.01).
doi:10.1371/journal.pone.0064372.g002
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Effects of Resveratrol on Superoxide Dismutase (SOD),
Catalase (CAT) and Glutathione Peroxidase (GPx) Activity
In order to determine the effect of resveratrol on antioxidant
cellular defenses, we studied the activities of SOD, CAT and GPx
(Fig. 8). Resveratrol was able to increase only the activity of SOD
(from 2.760.1 to 3.160.1 U/mg protein) compared to control
conditions (Fig. 8A). The H2O2-induced oxidative stress decreased
SOD (to 1.960.1 U/mg protein) (Fig. 8A) and CAT (from
14.261.3 to 12.861.1 U/mg protein) (Fig. 8B) activities, and
these effects were prevented by resveratrol. Resveratrol and H2O2
did not affect GPx activity (Fig. 8C). However, resveratrol
decreased GPx activity (20%) under H2O2 exposure.
Resveratrol Increased Extracellular GSH Levels
Resveratrol per se is able to modulate GSH, the main antioxidant
of CNS, increasing intracellular GSH content in C6 cells [17].
Here, we demonstrated that resveratrol increased extracellular
GSH levels, by about 13%, compared to the control conditions
(Table 1). Resveratrol also increased GSH extracellular content
after the H2O2 exposure. To verify the effect of resveratrol on
extracellular GSH was dependent of HO1, we pre-treated the cells
with ZnPP IX. HO1 inhibitor prevented the increase of
extracellular GSH induced by resveratrol.
Resveratrol Prevented the H2O2-stimulated TNFa Levels
To determine whether resveratrol could modulate the proin-
flammatory cytokines under H2O2 exposure, we measured the
TNFa levels. Resveratrol per se did not affect the levels of TNFa,
but was able to completely prevent the augment induced by H2O2
exposure, decreasing the levels of this cytokine, from 130610 to
9968 (Table 1). We examined whether the effect of resveratrol
was dependent of HO1 and pre-treated the cells with HO1
Figure 3. Resveratrol increased HO1 expression. Cells were pre-
treated for 1 h with 100 mM resveratrol (RSV) followed by the addition
of 1 mM H2O2 for 0.5 h. Western blot for HO1 was performed as
described in the Experimental procedures section. Data are expressed
as percentage of control value (assumed to be 100%) and represent the
optical density (OD) of mean 6 S.E.M of three independent
experimental determinations performed in triplicate, analyzed statisti-
cally by two-way ANOVA followed by the Tukey’s test. (a) indicates
significant differences from control (P,0.01). (b) indicates significant
differences from H2O2 (P,0.01).
doi:10.1371/journal.pone.0064372.g003
Figure 4. Effects of resveratrol on intracellular ROS production.
Cells were pre-treated for 1 h with 100 mM resveratrol (RSV) followed by
the addition of 1 mM H2O2 for 0.5 h. Cells were also pre-incubated for
0.5 h with ZnPP IX (10 mM), a HO1 inhibitor, before the pre-treatment
with resveratrol. Intracellular ROS production was measured as
described in the Experimental procedures section. Data are expressed
as percentage of control value and represent mean 6 S.E.M of three
independent experimental determinations performed in triplicate,
analyzed statistically by two-way ANOVA followed by the Tukey’s test.
(a) indicates significant differences from control (P,0.05). (b) indicates
significant differences from H2O2 (P,0.05) and (c) indicates significant
differences from ZnPP IX inhibitor (P,0.05).
doi:10.1371/journal.pone.0064372.g004
Figure 5. Effects of resveratrol on TAR levels. Cells were pre-
treated for 1 h with 100 mM resveratrol (RSV). After pre-treatment, cells
were exposed to 1 mM H2O2 for 0.5 h. TAR levels were measured as
described in the Experimental procedures section. The basal TAR levels,
assumed to be 100%, are indicated by the line. Each value is the mean
6 S.E.M of three independent experimental determinations performed
in triplicate, analyzed statistically by two-way ANOVA followed by the
Tukey’s test. (a) indicates significant differences from control (P,0.001).
(b) indicates significant differences from H2O2 (P,0.001).
doi:10.1371/journal.pone.0064372.g005
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inhibitor, which blocked the effect of resveratrol on H2O2-
stimulated TNFa levels.
Discussion
The effect of resveratrol in the brain has been studied in a
variety of pathological events, including carcinogenesis [53],
ischemic injury [54] and neurodegenerative disorders [15,16,55].
However, the cellular mechanisms underlying resveratrol-induced
selective protection to the neural system needs to be better
elucidated. The present data shows that resveratrol is able to
modulate important antioxidant defenses in C6 astrocyte cell line.
High concentrations of H2O2 induce oxidative-nitrosative stress,
which can lead to lipid, protein and DNA oxidation, causing
cellular damage [56,57]. It is important to emphasize that in this
study H2O2 did not induce cell death, in agreement with other
studies of our group [17,41,58]. Resveratrol decreased NO levels
and RNS (possibly peroxynitrite) implicated in the pathogenesis of
neurodegenerative disorders like Alzheimer’s and Parkinson’s
diseases [34]. Peroxynitrite, resulted by the reaction between
NO and superoxide anion, is one of the main molecules
responsible for the cellular damage in neurodegenerative disorders
[34].
Oxidative stress upregulates the expression of iNOS and
presumably would lead to increase in the NO concentrations
[16]. NO is synthesized during the stoichiometric conversion of L-
arginine to L-citrulline in the presence of oxygen and nicotinamide
adenine dinucleotide phosphate (NADPH), which is catalyzed by
NOS [59]. Our results have indicated that resveratrol decreases
iNOS expression. Previous works already demonstrated that
resveratrol may act through iNOS [16,60,61]. Thus, these results
suggest that resveratrol may have a protective effect against
diseases associated with increase in iNOS synthesis and NO levels.
Resveratrol per se was also able to modulate the activity of HO1.
Recently, Sakata et al, 2010 [30] showed that HO1 might be a
unique candidate by which resveratrol can induce an endogenous
cellular pathway which leads to building cellular and/or organ
resistance to stress, indicating a neuroprotective effect. In
agreement with Sakata, we showed that resveratrol, via HO1,
has antioxidant effects and thus could explain the actions of
resveratrol in CNS [7]. Furthermore, there is a relationship
between HO1 and iNOS. The nuclear factor-erythroid-2-related
factor 2 (Nrf2) regulates the transcription of HO1, which acts as a
scavenger of NO [31]. Nrf2 also mediates neuroprotection and
modulates several detoxification genes that encode antioxidant
proteins, such as GSH system and thioredoxin, regulators of
intracellular redox environment [61,62,63,64]. Resveratrol acti-
vates Nrf2 and all these regulators [61,64,65,66,67,68,69,70].
Excess of NO acts as a positive signal to increase HO1, which in
turn, is able to scavenge NO and block the activity of iNOS, to
prevent further NO production. Resveratrol, under oxidative
conditions, induced a decrease in iNOS and an increase in HO1
immunocontent. Thus, HO1 can also be critical to signaling
antioxidant response of resveratrol.
Besides, resveratrol decreased DCFH oxidation and prevented
H2O2-oxidative insult. This suggests strong antioxidant properties
for this polyphenol [71]. Excessive free radical, such as peroxyni-
trite, can lead to lipid, protein and DNA oxidation; and these
events are associated to age-related diseases [16,72]. Our group
has been demonstrated that resveratrol modulates glutamate
metabolism and protects against genotoxicity, probably by their
scavenger properties and astrocyte activation [17,41]. Resveratrol
under oxidative insult inhibited iNOS and decreased DCFH
oxidation, emerging as an important molecule which provides
protection against cellular toxicity. Our data on intracellular ROS
production also indicated the involvement of HO1 signaling
pathway in the protective mechanism of resveratrol against H2O2-
induced oxidative stress.
TAR levels represent the antioxidant capacity of cells and
resveratrol was able to increase TAR levels by about 50%. This
suggests that resveratrol displays antioxidant effects, protecting
cells against oxidative damage. It might avoid free radical
generation and improve antioxidant defenses, such as GSH
Figure 6. Resveratrol prevented mitochondrial dysfunction.
Cells were pre-treated for 1 h with 100 mM resveratrol (RSV). After pre-
treatment, cells were exposed to 1 mM H2O2 for 0.5 h. Mitochondrial
membrane potential was measured as described in the Experimental
procedures section. The control conditions, assumed to be 100%, are
indicated by the line. Each value [the ratio of 590 nm (red fluorescent J-
aggregates)/540 nm (green monomeric)] is the mean 6 S.E.M of three
independent experimental determinations performed in triplicate,
analyzed statistically by two-way ANOVA followed by the Tukey’s test.
(a) indicates significant differences from control (P,0.05). (b) indicates
significant differences from H2O2 (P,0.05).
doi:10.1371/journal.pone.0064372.g006
Figure 7. Effects of resveratrol on CK activity. Cells were pre-
treated for 1 h with 100 mM resveratrol (RSV). After pre-treatment, cells
were exposed to 1 mM H2O2 for 0.5 h. CK activity was measured as
described in the Experimental procedures section. Data represent mean
6 S.E.M of three independent experimental determinations performed
in triplicate, analyzed statistically by two-way ANOVA followed by the
Tukey’s test. (a) indicates significant differences from control (P,0.05).
(b) indicates significant differences from H2O2 (P,0.05).
doi:10.1371/journal.pone.0064372.g007
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[73,74,75]. H2O2 decreased TAR levels. This effect elicited by
resveratrol has been mainly attributed to its intrinsic antioxidant
properties. However, it is important to mention that it is also able
to modulate diverse cell activities independently of its antioxidant
properties [76].
The mitochondrial membrane potential has been implicated as
a factor in impaired mitochondrial function [77]. The impairment
in this organelle have been shown to occur in various models of
cell injury [32]. A decrease in mitochondrial membrane potential
following an intense production of ROS and RNS induces
mitochondrial disruption, inhibition of mitochondrial respiratory
chain, reduction in ATP synthesis and cell death [78]. In this
sense, in our study H2O2 generates high levels of ROS/RNS that
induce mitochondrial membrane potential dysfunction. Resvera-
trol totally prevent this damage. In addition, brain cells contain
antioxidative defense mechanisms that can protect against
oxidative damage and resveratrol may be a key regulator of these
defenses.
We also showed that although resveratrol did not modify CK
activity per se, it was able to prevent H2O2-induced CK activity
decrease. CK consists of a family of enzymes involved in high-
energy consuming tissues such as brain and skeletal muscle and it
is also very sensitive to oxidative damage (oxidation and nitration).
Considering that CK contains in its active site sulphydryl group
extremely important for their full operation, it is proposed that
reduced activity is related to increase in ROS/RNS production
induced by H2O2, which could oxidize thiol groups, contributing
to CK activity inhibition [79]. The marked reduction of CK
activity is reported in the brain of patients with oxidative-stress
linked neurodegenerative diseases, such as Alzheimer’s and
Parkinson’s diseases [79]. This indicates that resveratrol can
display in vivo function on CK activity in pathologies related to
redox imbalance.
The levels of free radicals can be determined by the balance
Figure 8. Effects of resveratrol on SOD, CAT and GPx activity.
Cells were pre-treated for 1 h in the presence of 100 mM resveratrol
(RSV) followed by the addition of 1 mM H2O2 for 0.5 h. SOD (A), CAT (B)
and GPx (C) activities were measured as described in the Experimental
procedures section. All data represent mean 6 S.E.M. of three
independent experimental determinations performed in triplicate,
analyzed statistically by two-way ANOVA followed by the Tukey’s test.
(a) indicates significant differences from control (P,0.05). (b) indicates
significant differences from H2O2 (P,0.05).
doi:10.1371/journal.pone.0064372.g008
Table 1. Effect of resveratrol on extracellular GSH content
and TNFa levels.
Treatments Extracellular GSH TNFa
RSV 11366 (a) 101610
H2O2 90610 130610 (a)
RSV+H2O2 11167 (a, b) 9968 (b)
ZnPP IX 9866 9869 (b)
RSV+ZnPP IX 10268 (b) 9768 (b)
H2O2+ ZnPP IX 88610 (a) 127612 (a, c)
RSV+H2O2+ ZnPP IX 8768 (a, c) 125612 (a, c)
Cells were pre-treated for 1 h in the presence of 100 mM resveratrol (RSV)
followed by the addition of 1 mM H2O2 for 0.5 h. Cells were also pre-incubated
for 0.5 h with ZnPP IX (10 mM), a HO1 inhibitor, before the pre-treatment with
resveratrol. Extracellular GSH and TNFa levels were measured as described in
the Experimental procedures section. Data are expressed as percentage of
control value (assumed to be 100%) and represent mean 6 S.E.M. of three
experimental determinations performed in triplicate, analyzed statistically by
two-way ANOVA followed by the Tukey’s test. (a) indicates significant
differences from control (P,0.05). (b) indicates significant differences from
H2O2 (P,0.05) and (c) indicates significant differences from ZnPP IX inhibitor
(P,0.05).
doi:10.1371/journal.pone.0064372.t001
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between their rate of production and clearance by various
antioxidant compounds and enzymes such as SOD, CAT and
GPx. Resveratrol prevented completely the H2O2-effect reestab-
lishing SOD activity, which in turn can decrease superoxide
radicals [80,81]. In this context, modulation of SOD activity by
resveratrol is very important to the neuroprotective effect
associated to oxidative stress. However, we also observed an
increase in CAT activity compared to oxidative insult, showing
that the H2O2 is decomposed to water [26,82]. Resveratrol
decreases the GPx activity under H2O2-induced oxidative stress,
improving the levels of GSH, the major brain antioxidant,
produced by astrocytes. As many redox-active compounds
modulate major enzymatic defenses against free radical action
[83,84,85,86], the anti- or pro-oxidant role is determined by the
set of their actions and cell types studied [5,35].
We have been showed that resveratrol modulates astroglial
parameters related to glutamate metabolism [14,17,42] including
the increase in glutamate uptake (probably by increase in EAAC1
expression) and GSH levels. GSH is secreted by astrocytes and
serves as a substrate to neuronal GSH synthesis [80,87]. Metal
chelators, SOD and antioxidants (e.g. resveratrol) inhibit the
oxidation of GSH, when it is secreted by astrocytes [80].
Moreover, the increase in GSH levels in glial cells confers
neuroprotection in neurodegenerative diseases, such as Alzhei-
mer’s and Parkinson’s diseases [27,88]. In this sense, resveratrol
increases extracellular GSH levels. The effect of resveratrol on
extracellular GSH probably involves the HO1 pathway. In
addition, Escartin et al, 2011 [89] reported that Nrf2, the
upregulator of HO1, facilitates the glutathione synthesis by
regulation of EAAC1, the main glutamate transporter present in
C6 astroglial cells. The increase in GSH biosynthesis through Nrf2
also protected glial cells against oxidative damage [90].
Lee et al, 2010 [88] demonstrated that a depletion of GSH in
glial cells induces inflammatory response. TNFa plays important
roles in ROS production [91] and it also potentiates NO
production in astrocytes [92]. Thus, an extracellular stimulus
such as H2O2 induces an increase in ROS/RNS production and
in TNFa levels. In this sense, resveratrol was able to prevent the
proinflammatory cytokine increase induced by H2O2 exposure,
probably by HO1 pathway, an upstream signal transduction of
nuclear factor-kB (NF-kB) and iNOS expression [31]. Even
though its mechanism of action remains not fully understood,
resveratrol may exert its effects by antioxidant/scavenger activity,
by modulation of NO metabolism and HO1 expression or by anti-
inflammatory effect [6,16,29,30,93,94,95,96].
In summary, we demonstrated the cytoprotective effects of
resveratrol against oxidative damage in C6 astrocyte cell line. The
main conclusions of this study are depicted in Fig. 9, which
displays that resveratrol strongly prevented the increase in ROS/
RNS production, iNOS expression and TNFa levels induced by
H2O2 in C6 astrocyte cell line and the putative involvement of
HO1 activation in the glioprotective role of resveratrol. H2O2
exposure induced decrease in mitochondrial membrane potential,
TAR levels, SOD, CAT and CK activity and resveratrol was also
able to protect glial cells. Moreover, resveratrol per se increased the
HO1 expression, the TAR levels, SOD activity and extracellular
GSH content and decreased the basal levels of ROS/RNS. Our
results suggest that resveratrol modulates important functions
related to the maintenance of the cellular redox environment
through HO1 signaling pathway. Overall, these observations
suggest that resveratrol may potentially be useful for therapeutic
purposes as a potent inducer of HO1 for the protection of glial
cells against oxidative response.
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